Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

69.57
+0.75001.09%
Pre-market: 71.001.43+2.06%04:12 EDT
Volume:652.84K
Turnover:45.16M
Market Cap:7.33B
PE:62.42
High:69.65
Open:68.85
Low:68.24
Close:68.82
52wk High:117.33
52wk Low:33.34
Shares:105.37M
Float Shares:86.88M
Volume Ratio:0.94
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.11
EPS(LYR):1.35
ROE:21.70%
ROA:8.36%
PB:11.53
PE(LYR):51.40

Loading ...

Gary Charles Robb, Chief Business Officer, Reports Disposal of Common Shares of Corcept Therapeutics Incorporated

Reuters
·
10 hours ago

The Market Game of the Quantitative King: How Renaissance Technologies Locks in Excess Returns Amid the 2025 Turmoil

TradingKey
·
Aug 14

William Guyer, Chief Development Officer, Reports Disposal of Corcept Therapeutics Common Shares

Reuters
·
Aug 13

How Corcept's Earnings Beat and Buyback Expansion Could Shape Investor Expectations for CORT

Simply Wall St.
·
Aug 09

Chief Development Officer William Guyer Reports Disposal of Common Shares of Corcept Therapeutics Incorporated

Reuters
·
Aug 08

Corcept Therapeutics Advances in Ovarian Cancer Treatment with New Phase 2 Study

TIPRANKS
·
Aug 08

Joseph Douglas Lyon, Officer, Reports Disposal of Common Shares of Corcept Therapeutics Incorporated

Reuters
·
Aug 06

Is Corcept Therapeutics' Steady Q2 Earnings Shaping Perceptions of Long-Term Consistency for CORT?

Simply Wall St.
·
Aug 02

Corcept Therapeutics’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
Aug 02

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Aug 01

Stock Track | Corcept Therapeutics Plummets 5.42% as Analysts Slash Price Targets

Stock Track
·
Aug 01

Corcept Therapeutics price target lowered to $121 from $131 at Piper Sandler

TIPRANKS
·
Aug 01

Corcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches

TIPRANKS
·
Aug 01

U.S. RESEARCH ROUNDUP-Alnylam, Amazon, Appfolio

Reuters
·
Aug 01

Corcept Therapeutics Inc : Piper Sandler Cuts Target Price to $121 From $131

THOMSON REUTERS
·
Aug 01

Earnings Flash:(CORT) Corcept Therapeutics Q2 EPS $0.29 Vs. FactSet Est. $0.19

MT Newswires Live
·
Aug 01

Corcept Therapeutics Q2 EPS $0.29 Beats $0.19 Estimate, Sales $194.430M Miss $199.395M Estimate

Benzinga
·
Aug 01

BRIEF-Corcept Therapeutics Q2 EPS USD 0.29

Reuters
·
Aug 01

Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome

TIPRANKS
·
Jul 31

Corcept Therapeutics Inc expected to post earnings of 19 cents a share - Earnings Preview

Reuters
·
Jul 30